Compare Tapestry, Inc. (TPR) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tapestry, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Tapestry, Inc. trades at $114.76 (market cap $22.67B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Tapestry, Inc. is the larger of the two by market cap, and Tapestry, Inc. pays the higher dividend (1.63%). Which is the better fit depends on your goals.
| TPR | ZBH | |
|---|---|---|
Market Cap | $22.67B | $18.05B |
Sector | Consumer Cyclical | Health |
52-Week High | $164.78 | $104.26 |
52-Week Low | $98.81 | $79.58 |
Enterprise Value | $25.47B | $25.11B |
Dividend Yield | 1.63% | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TPR trades at $117.58, down 3.73% amid bearish technical signals, though oversold RSI readings suggest potential near-term support. The company maintains strong profitability with 77.82% gross margins and has beaten earnings estimates for three consecutive quarters. Recent news highlights international growth acceleration in China and Europe, while analyst consensus remains strongly bullish with a $182.44 price target representing 55% upside potential.
The stock presents a compelling value opportunity given the disconnect between strong fundamentals and recent price weakness. Key catalysts include continued international expansion and margin improvement targets, though risks include Kate Spade execution challenges, tariff pressures, and premium valuation multiples that may limit near-term upside.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tapestry, Inc.
Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
